SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-17-000049
Filing Date
2017-06-22
Accepted
2017-06-22 16:34:07
Documents
1
Period of Report
2017-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K 2017 ANNUAL MEETING 062017 a8-k2017annualmeeting062017.htm 8-K 44212
  Complete submission text file 0001274644-17-000049.txt   45401
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 17925463
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences